A detailed history of Napean Trading & Investment CO (Singapore) Pte LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Napean Trading & Investment CO (Singapore) Pte LTD holds 18,332 shares of CRL stock, worth $3.41 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
18,332
Previous 10,275 78.41%
Holding current value
$3.41 Million
Previous $2.12 Billion 70.11%
% of portfolio
0.88%
Previous 0.5%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $1.51 Million - $1.98 Million
8,057 Added 78.41%
18,332 $3.61 Billion
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $2.09 Million - $2.81 Million
10,275 New
10,275 $2.78 Billion

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Napean Trading & Investment CO (Singapore) Pte LTD Portfolio

Follow Napean Trading & Investment CO (Singapore) Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napean Trading & Investment CO (Singapore) Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Napean Trading & Investment CO (Singapore) Pte LTD with notifications on news.